(R)-5-Amino-2-((tert-butoxycarbonyl)amino)pentanoic acid, 95.0%, 10g

4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-2-(trifluoromethyl)phenol, 95.0%, 250mg

5-Fluoroquinazoline-2,4(1H,3H)-dione, 95.0%, 1g

2,2,3,3-Tetrafluoro-2,3-dihydro-1,4-benzodioxine, 98%, 250mg

RACEMIC CIS-6-OXO-OCTAHYDRO-PYRROLO[3,4-C]PYRIDINE-2-CARBOXYLIC ACID TERT-BUTYL ESTER, 95.0%, 1g

2-(BOC-AMINO)-2-(OXETAN-3-YL)ACETIC ACID, 95.0%, 1g

1,2,3,4-Tetramethylbenzene, 95.0%, 25g

(S)-3-(4-Benzyloxy-phenyl)-2-hydroxy-propionic acid methyl ester, 97.0%, 1g

4-(4-bromophenyl)-2-methylnicotinonitrile, 95.0%, 5g

4-(Isopropylamino)benzonitrile, 95.0%, 500mg

GC-Kapillarsäule ROTI®Cap-1, unpolar, L 25 m, Ø-Innen 0,53 mm, Filmd. 2,00 µm, 1 Stück

3-HYDRAZINYL-5-(TRIFLUOROMETHYL)PYRAZOLE, 95.0%, 10g

(2S)-6-amino-2-[(2S)-2-(2-aminoacetamido)-3-(1H-imidazol-5-yl)propanamido]hexanoic acid; acetic acid, 98%, 5g